Concepedia

Daniel F. Wyss

DF

Statistics

Publications

48

Citations

6.4K

H-Index

34

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Novartis (United Kingdom)

Daniel F. Wyss is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, natural sciences, and molecular biology.

Top concepts

MedicineNatural SciencesBiochemistryMolecular BiologyImmunologyPharmacologyDrug DiscoveryStructural BiologyCell BiologyTumor Biology

Publications per year

1991–2023

48

Publications

48

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

Tumor Biology, Radiology, Oncology +10

Anterior Femoroacetabular Impingement

Martín Beck, Michael Leunig, Javad Parvizi et al. · Clinical Orthopaedics and Related Research · 2004 · 851 citations

Hip Arthroplasty, Femoroacetabular Impingement, Distraction Osteogenesis +11

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

Antitumor Activity, Immunology, Immunoediting +19

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Conformation and Function of the N-Linked Glycan in the Adhesion Domain of Human CD2

Daniel F. Wyss, Johnathan S. Choi, Jing Li et al. · Science · 1995 · 309 citations

1–5 of 48